Purpose Although many studies have been performed to evaluate whether or not apolipoprotein E gene (APOE) polymorphisms are differentially associated with bone mineral density (BMD) and fractures, the results have been conflicting. This large-scale study was performed to investigate whether a relationship exists between APOE polymorphisms and risk of fracture. Methods A hospital-based case-control study was conducted in 3,000 patients with fractures and 3,000 age-and gendermatched healthy controls. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay was applied to assess the APOE gene polymorphisms. Results Patients with fractures had a significantly higher frequency of APOE E2/E2 genotype [odds ratio (OR)=2.02, 95 % confidence interval (CI)=1.30, 3.14; P=0.002] than healthy controls. When stratifying by fracture type, it was found that patients with vertebral fractures had a significantly higher frequency of APOE E2/E2 genotype (OR=2.86, 95 % CI=1.73, 4.73; P<0.001). No significant differences were found in nonvertebral (hip or wrist or other) fractures. Conclusions Our study suggests that APOE E2/E2 genotype is a potential genetic risk factor for vertebral fractures in humans.
Introduction
Osteoporosis is a common skeletal disorder characterized by low bone mass and microarchitectural deterioration of bone tissue with increased susceptibility to fracture [1, 2] . It is a major public health issue. The World Health Organization estimates that 200 million women and men suffer from osteoporosis worldwide [3] . Osteoporosis has a complex etiology and is considered a multifactorial polygenic disease. Genetic factors may play a role in the development of osteoporosis [4] [5] [6] . Different polymorphisms have been described in several genes. Although a large number of association studies have been performed, the individual contribution of these polymorphisms to the pathogenesis of osteoporosis remains to be universally confirmed [7] [8] [9] .
Apolipoprotein E (apoE), a 299-amino acid, arginine-rich glycoprotein, is an integral surface component of chylomicrons, very-low-density lipoproteins, and some subclasses of high-density lipoproteins [10, 11] . The APOE gene is polymorphic, consisting of three common alleles (E2, E3, and E4) and six different genotypes (E2/E2, E2/E3, E2/E4, E3/E3, E3/ E4 and E4/E4) [11] . A recent study strongly underlined the general importance of apoE as a regulator of bone metabolism and identified the APOE epsilon2 (E2) allele as a potential genetic risk factor for low trabecular bone mass and vertebral fractures in humans [12] [13] [14] .
Although many studies have been performed to evaluate whether or not APOE polymorphisms are differentially associated with bone mineral density (BMD) and fractures, the results have been conflicting [15] [16] [17] [18] [19] . This large-scale study was performed to investigate whether a relationship exists between APOE polymorphisms and risk of fracture.
healthy controls during the years 2005 to 2013 from the Changhai Hospital Affiliated to the Second Military Medical University, China. All fractures were confirmed by two physicians who reviewed the hospital records and validated each case. For analyses on osteoporotic fractures, we included all fractures, except fractures of the hand, foot, skull, and face. We also excluded pathological and postprocedural fractures. If any of the three vertebral heights (anterior, central, or posterior) showed a minimum decrease of at least 4.6 mm and 15 % in absolute height on the later film, it was considered an incident fracture. The healthy control subjects were matched with the patients for age and sex. Healthy control subjects were recruited from the Changhai Hospital Affiliated to the Second Military Medical University where they were attending a clinic for routine examination. The Ethical Committee of the Changhai Hospital Affiliated to the Second Military Medical University approved the study protocols, and all participants gave written informed consent according to the Declaration of Helsinki.
DNA extraction and genotyping
The commercially available Qiagen kit (QIAGEN Inc., Valencia, CA, USA) was used to extract DNA from peripheral blood leukocytes. Genomic DNA was isolated from 20 g/L ethylenediaminetetraacetic acid (EDTA) or sodium citrate anticoagulated 3-5 ml venous blood and stored at 4°C. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay was applied to assess the APOE gene polymorphisms. Based on the GenBank reference sequence, the PCR primers were as follows: sense, ACAGAATTCGCCCCGGCCTG GTACAC; antisense, TAAGCTTGGCACGGCTGTCC AAGGA. The amplified DNA was digested with Hha I at 37°C for two hours. The digested PCR products were analysed by 6 % polyacrylamide gel electrophoresis (PAGE) and stained with ethidium bromide for visualization under UV light. For quality control, all genotyping personnel were blinded to clinical and neuroimaging data.
Statistical analysis
Comparisons between groups were made with chi-square test (nominal data) or Student t-test (interval data). The allele and genotype frequencies of the folate metabolism gene in patients were compared to controls using the chisquare test. The Hardy-Weinberg equilibrium was tested for goodness-of-fit chi-square test with one degree of freedom to compare the observed genotype frequencies among the subjects with the expected genotype frequencies. A P-value was considered significant at a level of <0.05. All analyses were performed with Stata software (College Park, TX).
Results
The demographical and clinical features of the participants are shown in Table 1 . The mean age was 61.0 (±9.1) years for the fractures cases and 60.8 (±8.9) years for the controls. The 42.4 % participants were male for the fracture cases and 42.3 % for the controls. No significant differences were found between the cases and the controls in gender, age, body mass index (BMI), physical activity scale for the elderly (PASE), total cholesterol, triglycerides and smoking status (Table 1) .
Patients with fractures had a significantly higher frequency of APOE E2/E2 genotype [odds ratio (OR)=2.02, 95 % confidence interval (CI)=1.30, 3.14; P=0.002] than healthy controls (Table 2) . When stratifying by fracture type, it was found that patients with vertebral fractures had a significantly higher frequency of APOE E2/E2 genotype (OR=2.86, 95 % CI= 1.73, 4.73; P<0.001) ( Table 3) . No significant differences were found in nonvertebral (hip or wrist or other) fractures (Table 3) .
Discussion
Although many studies have been performed to evaluate whether or not APOE polymorphisms are differentially associated with BMD and fractures, the results have been conflicting, possibly because of variations in study design, small sample sizes, and heterogeneous populations, among other issues [19] . Some studies supported that there was an association between APOE polymorphisms and fractures. A study in 284 unrelated postmenopausal Japanese found that the APOE E4 allele was associated with a low bone mass [20] . A study in 219 hemodialysis patients showed that APOE genotype appears to be an important genetic risk factor for bone fracture BMI body mass index, PASE physical activity scale for the elderly [21] . A prospective study in 1,750 women showed that the APOE polymorphism may be a candidate gene for hip fractures among community dwelling nondemented women [22] . A community-based study of 899 older adults found that the APOE E4 allele appears to be a risk factor for hip fracture [23] . But other studies did not support such an association between APOE polymorphisms and fractures. A study of 327 women showed no association between bone mass parameters, hip or lower forearm fracture and APOE genotypes in a population of postmenopausal women and age-matched controls [17] . The Rotterdam study did not support the hypothesis that the APOE E4 allele risk allele was associated with BMD, increased bone loss, or an increased risk of osteoporotic fractures [18] . A lot of studies have been conducted to examine the association of genetic polymorphism and osteoporotic fracture. A meta-analysis of 5,834 women from 30 study groups suggested that XX homozygotes of the estrogen receptor may have higher BMD and also a decreased risk of fractures when compared with carriers of the x allele, whereas the PvuII polymorphism was not associated with either BMD or fracture risk [24] . A meta-analysis of 26 published studies including 7,849 participants suggested that the COL1A1 Sp1 alleles were associated with a modest reduction in BMD and a significant increase in risk of osteoporotic fracture, particularly vertebral fracture [25] . A meta-analysis of 13 studies including 1,279 cases and 6,069 controls conducted by Lei et al. suggested a modest but statistically significant association between the ESR1 PvuII pp genotype and vertebral fracture [26] . The meta-analysis of 17 studies including 2,112 fracture cases and 4,521 controls by Ji et al. suggested that there was a modest but statistically significant association between the BsmI bb genotypes of the vitamin D receptor gene and fracture [27] .
The APOE gene polymorphisms were also associated with many other diseases. A meta-analysis of 28 case-control studies provided evidence for an association between the APOE E4 allele and frontotemporal lobar degeneration [28] . A meta-analysis of experimental and human studies suggested an association between APOE gene expression and its gene polymorphism with nephrotic syndrome susceptibility [29] . A meta-analysis of 29 studies suggested that APOE gene polymorphisms was associated with the risk of vascular dementia [30] . A case-control study showed that the APOE epsilon polymorphism has the expected impact on the plasma lipid profile, and the rs4420638 G allele may counterbalance the deleterious effect of the E4 allele on low-density lipoproteinscholesterol levels in an Algerian population [11] . A casecontrol study found that APOE gene polymorphism was associated with maximal oxygen uptake levels after exercise training in Chinese young adults [31] . A hospital-based case-control study suggested that APOE E3/E4 genotype was associated with a higher lower-extremity deep venous thrombosis risk [32] . A meta-analysis of 45 studies found that APOE gene polymorphisms were associated with essential hypertension [33] . A meta-analysis of seven studies suggested n (%) P n(%) P n(%) P n(%) P n(%) P n(%) P an association between APOE E4 mutation and increased risk of recurrent pregnancy loss [34] . A meta-analysis of seven studies suggested that the APOE polymorphisms were associated with the risk of psoriasis, especially E2 and E3 alleles [35] . A meta-analysis included 29 studies which suggested that the APOE E4 allele was associated with an increased risk of developing cerebral infarction in a Chinese population [36] . A meta-analysis of 6,977 subjects provides evidence that APOE E2 mutation is associated with multiple sclerosis risk [37] .
A strength of this study was the relatively large sample size. There are some limitations to the present study that should be mentioned. First of all, although this study suggested that APOE E2/E2 genotype was a potential genetic risk factor for vertebral fractures in humans, more biological background data are needed to explain our results. Secondly, this study only considers a Chinese population that may limit the application of these findings to other ethnic populations. Thirdly, the current finding might involve gene-to-environment interactions, which were not explored in the present study. Finally, this is a hospital-based case-control study, so the selection bias cannot be avoided and the subjects may not be representative of the general population.
In conclusion, this study suggests that APOE E2/E2 genotype is a potential genetic risk factor for vertebral fractures in humans. However it is highly desirable that our findings are validated through replication in other case-control series.
